Sodium Glycididazole
Sodium Glycididazole is a pharmaceutical drug with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 33.3%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
33.3%
1 of 3 finished
66.7%
2 ended early
1
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Sodium Glycididazole Reduces the Adverse Reactions of Concurrent Chemoradiotherapy
A Trial of CMNa Combined With Concurrent Chemoradiotherapy for Locally Recurrent ESCC
A Trial of CMNa Combined With Preoperatie Concurrent Chemoradiotherapy for Locally Advanced ESCC
A Trial of CMNa Combined With Definitive Concurrent Chemoradiotherapy for Locally Advanced ESCC
A Clinical Trial of a Radiation Sensitizer in Radiochemotherapy for Thoracic Esophageal Squamous Carcinoma
Clinical Trials (5)
Sodium Glycididazole Reduces the Adverse Reactions of Concurrent Chemoradiotherapy
A Trial of CMNa Combined With Concurrent Chemoradiotherapy for Locally Recurrent ESCC
A Trial of CMNa Combined With Preoperatie Concurrent Chemoradiotherapy for Locally Advanced ESCC
A Trial of CMNa Combined With Definitive Concurrent Chemoradiotherapy for Locally Advanced ESCC
A Clinical Trial of a Radiation Sensitizer in Radiochemotherapy for Thoracic Esophageal Squamous Carcinoma
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5